INTEGRATED DRUG CREATION Trademark

Trademark Overview

On Tuesday, April 15, 2025, a trademark application was filed for INTEGRATED DRUG CREATION with the United States Patent and Trademark Office. The USPTO has given the INTEGRATED DRUG CREATION trademark a serial number of 99137348. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Wednesday, September 10, 2025. This trademark is owned by Absci Corporation. The INTEGRATED DRUG CREATION trademark is filed in the Treatment & Processing of Materials Services and Computer & Software Services & Scientific Services categories with the following description:

Scientific and technological consulting services relating to producing, assaying, and purifying biotechnological products; research and development in the pharmaceutical and biotechnology fields; services of biotechnical and pharmacological laboratories, namely, scientific and technological research relating to the production of biotechnological products for use in preparing pharmaceutical preparations; scientific and technological research relating to the production of biotechnological products for use in preparing pharmaceutical preparations, and scientific consultation related thereto; scientific research, namely, carrying out feasibility studies relating to the production of biotechnological products for use in preparing pharmaceutical preparations; discovery of pharmaceutical preparations, medicines and medicaments; technological services, namely, technological consultation relating to the production of biotechnological products for use in preparing pharmaceutical preparations; Bi...

Biotechnological services, namely, custom production and purification of biotechnological and pharmaceutical preparations, namely, hormones, antibodies, and proteins; biotechnological services, namely, custom production of cell lines to produce proteins, such as hormones, cytokines, antibodies and antibody fragments
integrated drug creation

General Information

Serial Number99137348
Word MarkINTEGRATED DRUG CREATION
Filing DateTuesday, April 15, 2025
Status641 - NON-FINAL ACTION - MAILED
Status DateWednesday, September 10, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesScientific and technological consulting services relating to producing, assaying, and purifying biotechnological products; research and development in the pharmaceutical and biotechnology fields; services of biotechnical and pharmacological laboratories, namely, scientific and technological research relating to the production of biotechnological products for use in preparing pharmaceutical preparations; scientific and technological research relating to the production of biotechnological products for use in preparing pharmaceutical preparations, and scientific consultation related thereto; scientific research, namely, carrying out feasibility studies relating to the production of biotechnological products for use in preparing pharmaceutical preparations; discovery of pharmaceutical preparations, medicines and medicaments; technological services, namely, technological consultation relating to the production of biotechnological products for use in preparing pharmaceutical preparations; Bioinformatics research services, namely, analyzing complex biological data through the use of artificial intelligence, and testing and evaluation of biologics through artificial intelligence; computer assisted biologics design involving the use of artificial intelligence technology; Biotechnological services, namely, discovery of biotechnological and pharmaceutical preparations, namely, hormones, antibodies, and proteins; biotechnological services, namely, discovery of cell lines to produce proteins, such as hormones, cytokines, antibodies and antibody fragments
Goods and ServicesBiotechnological services, namely, custom production and purification of biotechnological and pharmaceutical preparations, namely, hormones, antibodies, and proteins; biotechnological services, namely, custom production of cell lines to produce proteins, such as hormones, cytokines, antibodies and antibody fragments

Classification Information

International Class040 - Treatment of materials.
US Class Codes100, 103, 106
Class Status Code6 - Active
Class Status DateTuesday, April 15, 2025
Primary Code040
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, April 15, 2025
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAbsci Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressVancouver, WA 98683

Trademark Events

Event DateEvent Description
Tuesday, April 15, 2025NEW APPLICATION ENTERED
Tuesday, April 15, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, April 15, 2025APPLICATION FILING RECEIPT MAILED
Wednesday, September 10, 2025ASSIGNED TO EXAMINER
Wednesday, September 10, 2025NON-FINAL ACTION WRITTEN
Wednesday, September 10, 2025NON-FINAL ACTION E-MAILED
Wednesday, September 10, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, December 9, 2025APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Tuesday, December 9, 2025APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED

Related Keywords

creation drug integrated biotechnological pharmaceutical production namely preparations scientific technological products services relating